The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Orphan Nuclear Receptors: The Exotics of Xenobiotics
Open accessAbstract
nuclear receptor constitutive androstane receptor cytochrome P450 phenobarbital pregnenolone 16α-carbonitrile pregnane X receptor rifampicin steroid and xenobiotic receptor 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene retinoid X receptor Orphan nuclear receptors (NRs)1 include gene products that are structurally related to nuclear hormone receptors but lack known physiological ligands. It has become clear that orphan NRs represent a unique and pivotal resource to uncover new regulatory systems that impact both health and human diseases. In addition to production and clearance of endogenous hormones, mammals also confront numerous foreign chemicals (xenobiotics) such as ingested food, environmental pollutants, and carcinogens as well as prescription and non-prescription drugs. Such compounds may accumulate to toxic levels unless they are metabolized and eliminated, a process largely mediated by the supergene family of cytochrome P450 (CYP) enzymes. Expressed mainly in the liver and capable of recognizing an amazing diversity of xenobiotics, CYP enzymes catalyze the metabolic conversion of xenobiotics to polar derivatives that are more readily eliminated (for reviews, see Refs. 1Gonzalez F.J. Trends Pharmacol. Sci. 1992; 13: 346-352Abstract Full Text PDF PubMed Scopus (393) Google Scholar and 2Denison M.S. Whitlock Jr., J.P. J. Biol. Chem. 1995; 270: 18175-18178Abstract Full Text Full Text PDF PubMed Scopus (333) Google Scholar). Thus, CYP enzymes, especially members of the CYP 1–4 families, are crucial for xenobiotic detoxification and survival of organisms (for a review, see Ref. 3Waxman D.J. Arch. Biochem. Biophys. 1999; 369: 11-23Crossref PubMed Scopus (674) Google Scholar). Among CYP enzymes, the CYP3A and -2B isoenzymes are of particular medical significance. For example, the human CYP3A4 enzyme alone is involved in the metabolism of 50–60% of clinical drugs as well as neutraceuticals and herbal medicines (4Maurel P. Ioannides C. Cytochrome P450, Metabolic and Toxicological Aspects. CRC Press, Inc., Boca Raton, FL1996: 241-270Google Scholar). An additional 25–30% of these compounds are metabolized by the CYP2B isoenzymes. The combined metabolic versatility of CYP3A and -2B, coupled with their inducibility by xenobiotic substrates, constitutes a molecular basis for many clinical drug-drug interactions (4Maurel P. Ioannides C. Cytochrome P450, Metabolic and Toxicological Aspects. CRC Press, Inc., Boca Raton, FL1996: 241-270Google Scholar). Compounds that are strong CYP enzyme inducers such as glucocorticoids, phenobarbital (PB), or rifampicin (RIF) can dramatically affect the clearance of any co-consumed drug that is a substrate for the enzyme. Recently, St. Johns wort, a popular herbal remedy for depression, was found to trigger severe adverse drug-drug interactions with oral contraceptives, the HIV protease inhibitor indinavir, and the immunosuppressant cyclosporin as a consequence of activating the CYP3A system (Ref. 5Moore L.B. Goodwin B. Jones S.A. Wisely G.B. Serabjit-Singh C.J. Willson T.M. Collins J.L. Kliewer S.A. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 7500-7502Crossref PubMed Scopus (885) Google Scholar, and references therein). In 1992, the aryl hydrocarbon receptor was identified as a transcriptional sensor mediating the induction of CYP1A and -1B1 genes by dioxin and a variety of related polycyclic aromatic hydrocarbons (6Ema M. Sogawa K. Watanabe N. Chujoh Y. Matsushita N. Gotoh O. Funae Y. Fujii-Kuriyama Y. Biochem. Biophys. Res. Commun. 1992; 184: 246-253Crossref PubMed Scopus (371) Google Scholar). Aryl hydrocarbon receptor is a member of the basic helix-loop-helix family of transcription factors, and it was presumed that other basic helix-loop-helix proteins might control the CYP3A and -2B gene families. This turned out to be an incorrect assumption, and the molecular basis for induction of CYP3A and -2Bgenes remained largely unknown. A major conceptual challenge in defining the molecular mechanisms for xenobiotic response is thatCYP genes are induced by thousands of natural and synthetic compounds, and yet the inducibility of CYP enzymes shows clear target gene and species specificity. For example, the antibiotic RIF has been shown to be a specific CYP3A inducer in humans and rabbits, whereas pregnenolone 16α-carbonitrile (PCN), an anti-glucocorticoid, is a rodent-specific CYP3A inducer (Ref. 7Barwick J.L. Quattrochi L.C. Mills A.S. Potenza C. Tukey R.H. Guzelian P.S. Mol. Pharmacol. 1996; 50: 10-16PubMed Google Scholar, and references therein). Pharmacologic studies in cultured primary hepatocytes suggest that it is not the structure of CYP3A genes but rather species-specific cellular factor(s) that dictates the profile ofCYP3A inducibility (7Barwick J.L. Quattrochi L.C. Mills A.S. Potenza C. Tukey R.H. Guzelian P.S. Mol. Pharmacol. 1996; 50: 10-16PubMed Google Scholar). In the past 3–4 years, emerging evidence has increasingly pointed to a unique role for orphan NRs in the regulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genes homologous to the vertebrate xenobiotic sensor NR1I genes [pregnane X receptor, PXR; constitutive androstane receptor, CAR (46)] are absent”
From The Genome of the Sea Urchin Strongylocentrotus purpuratus (2006) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,534
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B. J., Jones, S. A., Hawkins‐Brown, D., MacKenzie, K. I., Latour, A. M., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,378
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Moore, L. B., Goodwin, B. J., Jones, S. A., Wisely, G. B., Serabjit‐Singh, C. J., Willson, T. M., Collins, J. L., & Kliewer, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130155097 · Cited by 946
SXR, a novel steroid and xenobioticsensing nuclear receptorPreprint
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 912
Self-citationIdentification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow‐Báckman, M., OHLSSON, R. I., Postlind, H., Blomquist, P., & Berkenstam, A. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 876
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
Synold, T. W., Dussault, I., & FORMAN, B. M. (2001) · Nature Medicine · doi:10.1038/87912 · Cited by 840
Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B. J., Liddle, C., Blanchard, S. G., Willson, T. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001215200 · Cited by 818
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-p, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 751
Self-citationWaxman, D. J. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1351 · Cited by 749
Honkakoski, P., Zelko, I. N., Sueyoshi, T., & Negishi, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5652 · Cited by 702
Research works printed but not linked: 2
- Baes, 1994, Mol. Cell. Biol., 14, 1544
- Howell, 1998, Drug Metab. Dispos., 26, 234
Cited by
Sorted by citations
Items 101–200 of 210
Grün, F., Venkatesan, R. N., Tabb, M. M., Zhou, C., Cao, J., Hemmati, D., & Blumberg, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206553200 · Cited by 40
Lynch, C., Mackowiak, B., Huang, R., Li, L., Heyward, S. A., Sakamuru, S., Wang, H., & Xia, M. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy242 · Cited by 36
Zolfaghari, R., & Ross, A. C. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(02)00267-3 · Cited by 38
Hinton, D. E., Segner, H. E., Au, D. W. T., Kullman, S. W., & Hardman, R. C. (2008) · CRC Press eBooks · doi:10.1201/9780203647295.ch7 · Cited by 34
Aoyagi, S., Trotter, K. W., & Archer, T. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)70009-1 · Cited by 34
Novel functions of PXR in cardiometabolic disease
Zhou, C. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.015 · Cited by 35
Animal Models of Xenobiotic Receptors in Drug Metabolism and Diseases
Gong, H., Sinz, M., Feng, Y., Chen, T., Venkataramanan, R., & Xie, W. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00034-0 · Cited by 32
Self-citationPsychophysiological stress: a significant parameter in drug pharmacokinetics
Konstandi, M. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.816283 · Cited by 31
Kocarek, T. A., Shenoy, S. D., Mercer-Haines, N. A., & Runge‐Morris, M. (2002) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(03)00002-9 · Cited by 31
Chen, C., Han, Y., Yang, Z., & Rodrigues, A. D. (2011) · Xenobiotica · doi:10.3109/00498254.2011.560971 · Cited by 30
Ozeki, J., Uno, S., Ogura, M., Choi, M., Maeda, T., Sakurai, K., Matsuo, S., Amano, S., Nebert, D. W., & Makishima, M. (2010) · Toxicology · doi:10.1016/j.tox.2010.11.003 · Cited by 30
Stahl, S. H., Davies, M. R., Cook, D. I., & Graham, M. J. (2008) · Xenobiotica · doi:10.1080/00498250802105593 · Cited by 31
Singh, A. K., Kashyap, M. P., Jahan, S., Kumar, V., Tripathi, V., Siddiqui, M. A., Yadav, S., Khanna, V. K., Das, V., Jain, S. K., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs213 · Cited by 30
Masuyama, H., Nakamura, K., Nobumoto, E., & Hiramatsu, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3611 · Cited by 30
Modulation of transcriptional activity by antioxidant carotenoids
Sharoni, Y., Agbaria, R., Amir, H., Ben-Dor, A., Bobilev, I., Doubi, N., Giat, Y., Hirsch, K., Izumchenko, G., Khanin, M., et al. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00033-5 · Cited by 30
Retinoid-xenobiotic interactions: the Ying and the Yang.
Shmarakov, I. O. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.05.05 · Cited by 29
Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice
Park, Y. J., Lee, E. K., Lee, Y., Park, D. J., Jang, H. C., & Moore, D. D. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.03.017 · Cited by 27
Dai, D., Pan, Y., Zeng, C., Liu, S., Yan, Y., Wu, X., Xu, Z., & Zhang, L. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108912 · Cited by 26
Qin, S., Chen, J., Tanigawa, S., & Hou, D. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.046 · Cited by 27
Cytochrome P450 2B6 is a growth‐inhibitory and prognostic factor for prostate cancer
Kumagai, J., Fujimura, T., Takahashi, S., Urano, T., Ogushi, T., Horie‐Inoue, K., Ouchi, Y., Kitamura, T., Muramatsu, M., Blumberg, B., et al. (2007) · The Prostate · doi:10.1002/pros.20597 · Cited by 24
Molecular mechanism of allosteric communication in the human PPARα‐RXRα heterodimer
Venäläinen, T., Molnár, F., Oostenbrink, C., Carlberg, C., & Peräkylä, M. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22613 · Cited by 23
CINPA1 binds directly to constitutive androstane receptor and inhibits its activity
Cherian, M. T., Chai, S. C., Wright, W. C., Singh, A., Casal, M. A., Zheng, J., Wu, J., Lee, R. E., Jr., Griffin, P. R., & Chen, T. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.029 · Cited by 23
Sabolovic, N., Heydel, J., Li, X., Little, J. M., Humbert, A., Radominska-p, A., & Magdalou, J. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.08.013 · Cited by 23
Brožová, E., Šimečková, K., Kostrouch, Z., Rall, J. E., & Kostrouchová, M. (2006) · Mechanisms of Development · doi:10.1016/j.mod.2006.06.006 · Cited by 21
Jiang, S., Wu, M.-S., Chen, L., Hung, M., Lin, H.-E., Chang, G.-G., & Chang, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.214 · Cited by 22
Santiago-Josefat, B., & Fernández-Salguero, P. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.08.020 · Cited by 23
Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential
Gong, H., & Xie, W. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.1.49 · Cited by 22
Self-citationEffects of Matrine and Oxymatrine on Catalytic Activity of Cytochrome P450s in Rats
Yuan, F., Chen, J., Wu, W., Chen, S., Wang, X., Zeng, S., & Huang, M. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00596.x · Cited by 21
Hahn, M. E., Merson, R. R., & Karchner, S. I. (2005) · Biochemistry and molecular biology of fishes · doi:10.1016/s1873-0140(05)80010-4 · Cited by 21
Cholesterol detoxification by the nuclear pregnane X receptor
Kliewer, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500159102 · Cited by 21
Shenoy, S. D., Spencer, T. A., Mercer-Haines, N. A., Abdolalipour, M., Wurster, W. L., Runge‐Morris, M., & Kocarek, T. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1302 · Cited by 21
Husain, I., Manda, V., Alhusban, M., Dale, O., Bae, J., Avula, B., Gurley, B., Chittiboyina, A., Khan, I., & Khan, S. I. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153416 · Cited by 21
Nuclear hormone receptors put immunity on sterols
Santori, F. R. (2015) · European Journal of Immunology · doi:10.1002/eji.201545712 · Cited by 18
Premalatha, R., Jubendradass, R., Rani, S. J. A., Srikumar, K., & Mathur, P. P. (2012) · Reproductive Sciences · doi:10.1177/1933719112459241 · Cited by 18
Isolation and characterization of Schistosoma mansoni constitutive androstane receptor
Hu, R., Wu, W., Niles, E. G., & LoVerde, P. T. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.02.017 · Cited by 18
Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription
Keppler, B. R., Archer, T., & Kinyamu, H. K. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.005 · Cited by 17
Dvořák, Z., Li, H., & Mani, S. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000860 · Cited by 16
Chen, C.-N., Shih, Y.-H., Ding, Y.-L., & Leong, M. K. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200310j · Cited by 17
Targeting the pregnane X receptor in liver injury
Li, T., Yu, R. T., Atkins, A. R., Downes, M., Tukey, R. H., & Evans, R. M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.715634 · Cited by 17
Self-citationInsecticide detoxification indicator strains as tools for enhancing chemical discovery screens
Shah, S., Yarrow, C., Dunning, R., Cheek, B., Vass, S. O., Windass, J. D., & Hadfield, S. T. (2011) · Pest Management Science · doi:10.1002/ps.2218 · Cited by 16
Wang, Y., Masuyama, H., Nobumoto, E., Zhang, G., & Hiramatsu, Y. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.003 · Cited by 16
Alterations in the distribution and orexigenic effects of dexamethasone in CAR-null mice
Qatanani, M., Wei, P. Y., & Moore, D. D. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.04.001 · Cited by 17
Design, synthesis and photochemical properties of caged bile acids
Hirayama, Y., Iwamura, M., & Furuta, T. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01074-0 · Cited by 16
Ayed‐Boussema, I., Pascussi, J., Rjiba, K., Maurel, P., Bacha, H., & Hassen, W. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2011.592194 · Cited by 15
The Pharmacogenomics of Sex Hormone Metabolism: Breast Cancer Risk in Menopausal Hormone Therapy
Justenhoven, C., Obazee, O. M., & Brauch, H. B. (2012) · Pharmacogenomics · doi:10.2217/pgs.11.144 · Cited by 15
Parente, T. E., Moreira, D. A., Magalhães, M. G. P., Andrade, P., Furtado, C., Haas, B. J., Stegeman, J. J., & Hahn, M. E. (2017) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2016.12.012 · Cited by 15
Husain, I., Dale, O., Manda, V., Ali, Z., Gurley, B., Chittiboyina, A., Khan, I., & Khan, S. I. (2021) · Planta Medica · doi:10.1055/a-1557-2113 · Cited by 13
Ishizawa, M., Ogura, M., Kato, S., & Makishima, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051664 · Cited by 13
Moon, Y. J., Zhang, S., Brazeau, D. A., & Morris, M. E. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600156 · Cited by 12
Anticancer Activity of Carotenoids
Stahl, W., Danilenko, M., Sharoni, Y., & Levy, J. (2004) · Oxidative stress and disease · doi:10.1201/9780203026649.ch8 · Cited by 12
Transcriptional Regulation of CYP2B6 Expression by Hepatocyte Nuclear Factor 3β in Human Liver Cells
Li, L., Li, D., Heyward, S. A., & Wang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150587 · Cited by 12
Richter, I., & Fidler, A. E. (2014) · Marine Drugs · doi:10.3390/md12115590 · Cited by 11
Novel steroid mimics directed towards the estradiol skeleton
Bridgeman, E., Cavill, J. L., Schofield, D. J., Wilkins, D. S., & Tomkinson, N. C. O. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.10.005 · Cited by 11
(2005) · Humana Press eBooks · doi:10.1385/1592598323 · Cited by 11
CYP2B6*6 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers
Abdullahi, S. T., Soyinka, J. O., Olagunju, A., Bolarinwa, R. A., Olarewaju, O. J., Bakare-Odunola, M. T., Winterberg, M., Tärning, J., Owen, A., & Khoo, S. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1527 · Cited by 9
Herb–Drug Interaction Potential of Licorice Extract and Paclitaxel: A Pharmacokinetic Study in Rats
Ha, Y., Wang, T.-R., Li, J., Li, J., Lu, R.-H., Li, J., Chen, L., & Gan, P.-P. (2019) · European journal of drug metabolism and pharmacokinetics · doi:10.1007/s13318-019-00593-5 · Cited by 8
Use of transgenic mice in UDP-glucuronosyltransferase (UGT) studies
Ou, Z., Huang, M., Zhao, L., & Xie, W. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903208983 · Cited by 9
Self-citationRioja, J., Bandrés, E., Costa, D. R., Mayans, A. R., Bergera, J. Z., Sanz, M. J. G., Sanz, L., García‐Foncillas, J., & Polo, J. M. B. (2007) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(07)73772-5 · Cited by 9
The effect of chronic kidney disease on CYP 2B expression and activity in male Wistar rats
Kucey, A. S., Velenosi, T. J., Tonial, N. C., Tieu, A., RaoPeters, A. A. E., & Urquhart, B. L. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.475 · Cited by 9
Mechanisms of Hepatocyte Organic Anion Transport
Wolkoff, A. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00054-3 · Cited by 8
Role of the nuclear pregnane X receptor in drug metabolism and the clinical response
(2015) · Receptors & Clinical Investigation · doi:10.14800/rci.996 · Cited by 6
Different profiles of hepatic alkoxyresorufin O‐dealkylase activities in small rodents
Chatuphonprasert, W., Rermraksakul, P., Udomsuk, L., Lao‐ong, T., & Jarukamjorn, K. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2756 · Cited by 6
Identification of Novel Nuclear Hormone Receptor Ligands by Activity-Guided Purification
Grün, F., & Blumberg, B. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)64001-2 · Cited by 6
Trauner, M., & Boyer, J. L. (2002) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200205000-00005 · Cited by 9
Lee, S. B., & Lee, S. H. (2006) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2006.12.001 · Cited by 5
Makishima, M., & Yamada, S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10079-4 · Cited by 5
Giroux, P. J., Kyle, P. B., Tan, C., Edwards, J. D., Nowicki, M. J., & Liu, H. (2022) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v13.i3.73 · Cited by 4
De Novo Assembly of the Genome of the Sea Urchin Paracentrotus lividus (Lamarck 1816)
Costantini, M., Esposito, R., Ruocco, N., Caramiello, D., Cordella, A., Ventola, G. M., & Zupo, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031685 · Cited by 4
Genotyping of the PXR A11156C polymorphism with locked nucleic acid containing fluorogenic probes
den Buijsch, R. A. M. O., Vries, J. E. D., Loots, W. J. G., Landt, O., Wijnen, P. A. H. M., van Dieijen‐Visser, M. P., & Bekers, O. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500299 · Cited by 4
Establishing Orphan Nuclear Receptors PXR and CAR as Xenobiotic Receptors
Li, T., Sonoda, J., & Evans, R. M. (2008) · Wiley eBooks · doi:10.1002/9780470409107.ch2 · Cited by 3
Self-citationNakagawa, M., Uno, S., Iriyama, N., Matsunawa, M., Makishima, M., Takeuchi, J., Tsuboi, I., Hatta, Y., & Takei, M. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.03.003 · Cited by 2
Estrogen Action and Breast Cancer
Fox, J., Liu, H., & Jordan, V. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_10 · Cited by 2
Endocrine and Paracrine Factors in Carcinogenesis
Heber, D., & Cohen, P. (2006) · Elsevier eBooks · doi:10.1016/b978-012088393-6/50069-5 · Cited by 2
Association of NR1I2 gene polymorphisms and time of progression to AIDS
de Medeiros, R. M., Menti, C. F., Benelli, J. L., Matte, M. C. C., de Melo, M. G., Almeida, S. E. D. M., & Fiegenbaum, M. (2017) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760160382 · Cited by 2
Karthikeyan, B. S., Suvaithenamudhan, S., Akbarsha, M. A., & Parthasarathy, S. (2017) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-017-0791-8 · Cited by 2
Bile Acid-Derived Vitamin D Receptor Ligands
Makishima, M., & Yamada, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00088-2 · Cited by 2
Rioja, J., Elizalde, E. B., Costa, D. R., Mayans, A. R., Bergera, J. Z., Sanz, M. G., Sanz, L., Foncillas, J. G., & Polo, J. M. B. (2007) · Actas Urológicas Españolas · doi:10.4321/s0210-48062007001000003 · Cited by 2
Estrogen Receptor Pathways and Breast Cancer
Peng, J., & Jordan, V. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_9 · Cited by 2
Pharmacokinetics and pharmacogenetics of tacrolimus in renal transplant patients
den Buijsch, R. A. M. O. (2007) · doi:10.26481/dis.20071025ro · Cited by 2
Mechanisms of Hepatocyte Organic Anion Transport
Wolkoff, A. W. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50060-x · Cited by 2
Jiang, X. (2004) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 1
Advances in Retinoid Research: Mechanisms of Cancer Chemoprevention Symposium Introduction
Ross, A. C. (2003) · Journal of Nutrition · doi:10.1093/jn/133.1.271s · Cited by 1
A new signaling pathway of dioxin receptor ligands through targeted protein degradation
Kato, S., Fujii‐Kuriyama, Y., & Ohtake, F. (2008) · Cited by 1
THE ROLE OF PXR AND IKKβ SIGNALING IN CARDIOMETABOLIC DISEASE
Helsley, R. N. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.040 · Cited by 1
Chapter 3 Nuclear Xenobiotic Receptors
He, J., & Xie, W. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)87003-8 · Cited by 1
Self-citationMechanisms of Hepatocyte Organic Anion Transport
Wolkoff, A. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00042-6 · Cited by 1
SXR and the xenobiotic response
Tabb, M. M., Zhou, C., & Blumberg, B. (2003) · Springer eBooks · doi:10.1007/978-4-431-66999-9_15 · Cited by 1
Transcriptional Regulation of UDP-Glucuronosyltransferases
Radominska-p, A., Mackenzie, P. I., & Xie, W. (2009) · Humana Press eBooks · doi:10.1385/1-59259-832-3:133 · Cited by 1
Self-citationBolander, F. F. (2004) · Elsevier eBooks · doi:10.1016/b978-012111232-5/50006-3 · Cited by 1
Nuclear Receptor‐Mediated Gene Regulation in Drug Metabolism
Wang, H., & Xie, W. (2008) · Wiley eBooks · doi:10.1002/9780470439265.ch17 · Cited by 1
Self-citationToxicity Analysis of Polycyclic Aromatic Hydrocarbon Mixtures
Naspinski, C. (2009) · OakTrust (Texas A&M University Libraries) · Cited by 1
Evolutionary analysis of mammalian genomes and associations to human disease
Vamathevan, J. J. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Determination of Regulation of Drug‐Metabolizing Enzymes and Transporters
Zhang, B., & Xie, W. (2011) · doi:10.1002/9781118067598.ch32
Self-citationAnimal Models of Xenobiotic Nuclear Receptors and their Utility in Drug Development
Gong, H., & Xie, W. (2008) · doi:10.1002/9780470409107.ch7
Self-citationNuclear Receptor‐Mediated Gene Regulation in Drug Metabolism
Wang, H., & Xie, W. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse116
Self-citationHormones and the cardiovascular system
Johnston, C. I. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.03.010
Selective Estrogen Receptor Modulators (SERMs) and Selective Androgen Receptor Modulators (SARMs)
Narayanan, R., & Dalton, J. T. (2015) · Springer eBooks · doi:10.1007/978-3-319-18729-7_11
TARGETS TO COMBAT OBESITY - AN REVIEW
Ramaiah, M. T. A. S. (2013) · International Journal of Pharma and Bio Sciences
Regulation of Transcription by Antioxidant Carotenoids
Sharoni, Y., Agbaria, R., Amir, H., Ben-Dor, A., Dubi, N., Giat, Y., Hirsch, K., Izumchenko, G., Khanin, M., Kirilov, E., et al. (2005) · AOCS Publishing eBooks · doi:10.1201/9781439822371.ch16
The Effect of AST-120 on Hepatic Metabolism and Transport in Chronic Kidney Disease
Kucey, A. S. (2016) · Scholarship@Western (Western University)
Metadata
- Authors
- Xie, W., & Evans, R. M.
- Affiliations
- Salk Institute for Biological Studies (US)
- Corresponding author
- Xie, Wen
- Evans, Ronald M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 276
- Issue
- 41
- Pages
- 37739-37742
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1983836083
- Cited by
- 210
- References
- 25
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 7 · 2015: 5 · 2014: 4 · 2013: 3 · 2012: 18
- FWCI
- 17.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- orphan nuclear receptor, xenobiotics, cytochrome P450, drug metabolism, CYP3A4, pregnane X receptor, constitutive androstane receptor, retinoid X receptor, drug-drug interactions, drug repurposing, drug toxicity
- MeSH terms
- Animals, Humans, Xenobiotics, Genome, Human, Receptors, Cytoplasmic and Nuclear, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review